Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Novartis MalaysiaNovartis Malaysia
VS
TakedaTakeda
Novartis Malaysia

Novartis Malaysia

Kuala Lumpur, MY

Last Update: 30/04/2026

View Profile
Between 750 and 799
https://www.novartis.com.my/
753/1000Fair

We strive to change the practice of medicine. To make discoveries that take medicine in new directions. Privacy Policy: https://www.novartis.com/my-en/privacy-policy Novartis LinkedIn Community Guidelines: https://www.novartis.com/guidelines/novartis-linkedin-communit...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:135
Subsidiaries:32
12-month incidents
0
Known data breaches
0
Attack type number
0
Takeda

Takeda

Tokyo, JP

Last Update: 20/05/2026

View Profile
Between 800 and 849
https://www.takeda.com/
813/1000Good

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:37,228
Subsidiaries:6
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Novartis Malaysia

Novartis Malaysia

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Takeda

Takeda

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis Malaysia in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Takeda in 2026.

Incidents

Incident History - Novartis Malaysia (X = Date, Y = Severity)

Novartis Malaysia cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Takeda (X = Date, Y = Severity)

Takeda cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Novartis Malaysia

Novartis Malaysia

Incidents
No explicit notable incidents reported.
Takeda

Takeda

Incidents
No explicit notable incidents reported.

FAQ

Between Novartis Malaysia company and Takeda company, which one has the best AI Cybersecurity Score ?
Between Novartis Malaysia company and Takeda company, which one has experienced more cyber incidents in the past ?
Between Novartis Malaysia company and Takeda company, which one has experienced more cyber incidents this year ?
Between Novartis Malaysia company and Takeda company, which one has experienced at least one ransomware attack ?
Between Novartis Malaysia company and Takeda company, which one has experienced at least one data breach ?
Between Novartis Malaysia company and Takeda company, which one has experienced at least one targeted cyberattack ?
Between Novartis Malaysia company and Takeda company, which one has experienced at least one vulnerability ?
Between Novartis Malaysia company and Takeda company, which one holds the most compliance certifications ?
Between Novartis Malaysia company and Takeda company, which one holds the fewest compliance certifications ?
Between Novartis Malaysia company and Takeda company, which one has the most subsidiaries ?
Between Novartis Malaysia company and Takeda company, which one has the largest number of employees ?
Between Novartis Malaysia and Takeda, which company holds both SOC 2 Type 1 certifications ?
Between Novartis Malaysia and Takeda, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Novartis Malaysia or Takeda ?
Which company is PCI DSS compliant - Novartis Malaysia or Takeda ?
Between Novartis Malaysia and Takeda, which company complies with HIPAA regulations for healthcare data ?
Between Novartis Malaysia and Takeda, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-66473
SUMMARY

Unauthenticated Broken Access Control in Xendit Payment <= 7.1.0 versions.

PUBLISHED
Date2026-07-27
UPDATED
Date2026-07-27
RISK INFORMATION (Score: 7.5)
CVSS3
Base Score: 7.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
3.9
REFERENCES
CVE-2026-65448
SUMMARY

Unauthenticated Cross Site Scripting (XSS) in Anti Spam and list cleaner &#8211; AcyChecker <= 1.8.1 versions.

PUBLISHED
Date2026-07-27
UPDATED
Date2026-07-27
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:L
IMPACT SCORE
3.7
EXPLOITABILITY
2.3
REFERENCES
CVE-2026-65447
SUMMARY

Unauthenticated Cross Site Scripting (XSS) in Contest Gallery <= 30.0.6 versions.

PUBLISHED
Date2026-07-27
UPDATED
Date2026-07-27
RISK INFORMATION (Score: 7.1)
CVSS3
Base Score: 7.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
IMPACT SCORE
3.7
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-65446
SUMMARY

Unauthenticated Cross Site Scripting (XSS) in Kali Forms <= 2.4.18 versions.

PUBLISHED
Date2026-07-27
UPDATED
Date2026-07-27
RISK INFORMATION (Score: 7.1)
CVSS3
Base Score: 7.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L
IMPACT SCORE
3.7
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-65445
SUMMARY

Unauthenticated Broken Access Control in Ad Invalid Click Protector (AICP) <= 1.3.0 versions.

PUBLISHED
Date2026-07-27
UPDATED
Date2026-07-27
RISK INFORMATION (Score: 6.5)
CVSS3
Base Score: 6.5
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:L/A:L
IMPACT SCORE
2.5
EXPLOITABILITY
3.9
REFERENCES